Format

Send to

Choose Destination
Psychiatr Clin North Am. 2000 Mar;23(1):169-92, ix.

Psychopharmacology of borderline personality disorder.

Author information

1
Department of Psychiatry, University of Pittsburgh, Pennsylvania, USA.

Abstract

Pharmacotherapy for patients with borderline personality disorder is directed against the psychobiology of cognitive-perceptual, affective, and impulsive-behavioral symptoms. A symptom-specific method using current empiric evidence for drug efficacy in each symptom domain is proposed. Drugs in each medication class have some potential utility against specific symptoms in patients with borderline personality disorder.

PMID:
10729938
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center